Stockscreener 앱 받기
175.55
0.89%
1.55
시장 영업 전:
175.79
0.24
+0.14%
전일 마감가:
$174.00
열려 있는:
$175
하루 거래량:
1.89M
Relative Volume:
0.94
시가총액:
$49.49B
수익:
$7.23B
순이익/손실:
$1.41B
주가수익비율:
35.26
EPS:
4.979
순현금흐름:
$1.09B
1주 성능:
+2.94%
1개월 성능:
+14.22%
6개월 성능:
+48.46%
1년 성능:
+24.42%
1일 변동 폭
$0.00
$0.00
1주일 범위
$169.90
$177.04
52주 변동 폭
$108.35
$177.05
애질런트 테크놀로지스 Stock (A) Company Profile
명칭
Agilent Technologies Inc
전화
(408) 345-8886
주소
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, NTRA, IQV
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
175.55 | 49.49B | 7.23B | 1.41B | 1.09B | 4.979 |
TMO
Thermo Fisher Scientific Inc
|
696.49 | 257.53B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
231.50 | 162.74B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
404.79 | 58.35B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
271.04 | 44.61B | 16.63B | 1.39B | 2.12B | 8.0674 |
애질런트 테크놀로지스 Stock (A) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-09-09 | 재개 | UBS | Neutral |
| 2026-07-09 | 재개 | Jefferies | Hold |
| 2026-06-26 | 재개 | Bernstein | Outperform |
| 2026-06-11 | 개시 | Piper Sandler | Neutral |
| 2026-05-28 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2026-05-27 | 개시 | RBC Capital Mkts | Outperform |
| 2026-01-20 | 개시 | HSBC Securities | Buy |
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-12-09 | 개시 | Goldman | Buy |
| 2025-12-02 | 개시 | Morgan Stanley | Overweight |
| 2025-10-08 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-10-08 | 업그레이드 | UBS | Neutral → Buy |
| 2025-02-10 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-04-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-11-17 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-31 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-05-24 | 재확인 | Barclays | Equal Weight |
| 2023-05-24 | 재확인 | BofA Securities | Buy |
| 2023-05-24 | 재확인 | Citigroup | Neutral |
| 2023-05-24 | 재확인 | Credit Suisse | Outperform |
| 2023-05-24 | 재확인 | Evercore ISI | Outperform |
| 2023-05-24 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | 재확인 | Robert W. Baird | Outperform |
| 2023-05-24 | 재확인 | SVB Securities | Outperform |
| 2023-05-24 | 재확인 | Stifel | Hold |
| 2023-05-24 | 재확인 | TD Cowen | Outperform |
| 2023-05-24 | 재확인 | Wells Fargo | Overweight |
| 2023-05-11 | 개시 | Barclays | Equal Weight |
| 2023-01-10 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-07-20 | 개시 | UBS | Buy |
| 2022-07-08 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | 재확인 | BofA Securities | Buy |
| 2022-02-23 | 재확인 | Citigroup | Buy |
| 2022-02-23 | 재확인 | Cowen | Outperform |
| 2022-02-23 | 재확인 | Evercore ISI | Outperform |
| 2022-02-23 | 재확인 | Stifel | Hold |
| 2022-02-23 | 재확인 | Wells Fargo | Overweight |
| 2021-11-23 | 재확인 | BofA Securities | Buy |
| 2021-11-23 | 재확인 | Cowen | Outperform |
| 2021-11-23 | 재확인 | Stifel | Hold |
| 2021-03-18 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-25 | 업그레이드 | UBS | Neutral → Buy |
| 2020-11-17 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | 개시 | Atlantic Equities | Neutral |
| 2020-08-19 | 재확인 | BofA Securities | Neutral |
| 2020-08-19 | 재확인 | Citigroup | Neutral |
| 2020-08-19 | 재확인 | Jefferies | Buy |
| 2020-08-19 | 재확인 | Robert W. Baird | Outperform |
| 2020-08-19 | 재확인 | SVB Leerink | Outperform |
| 2020-08-19 | 재확인 | Stifel | Hold |
| 2020-08-19 | 재확인 | Wells Fargo | Overweight |
| 2020-02-24 | 다운그레이드 | Needham | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-26 | 재확인 | Needham | Buy |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-10-18 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-07-16 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | 다운그레이드 | Barclays | Overweight → Equal Weight |
모두보기
애질런트 테크놀로지스 주식(A)의 최신 뉴스
Should You Invest in the First Trust Water ETF (FIW)? - Zacks Investment Research
Barclays Adjusts Price Target on Agilent Technologies to $195 From $175, Keeps Overweight Rating - marketscreener.com
Agilent Expands Oligonucleotide Manufacturing Capabilities With New Boulder Lab - CHEManager
Agilent Technologies Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.
Global Oligonucleotide Synthesis Reagents Market Size, Share, and Forecast, 2026-2033 | Therapeutics Demand Fuels 11.9% CAGR and USD 1.75 Billion Opportunity - GlobeNewswire Inc.
Magnetic Beads MarketGlobal Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 Billion - GlobeNewswire Inc.
Agilent Technologies To Go Ex-Dividend On October 6th, 2026 With 0.255 USD Dividend Per Share - Moomoo
A6533886 Bond Yield and Price — FINRA:A6533886 - TradingView
AIgnite Execution And Long Replacement Cycles Will Support This Fairly Valued Bullish Case - Simply Wall Street
A5886204 Bond Profile: Coupon and Redemption - TradingView
Agilent Technologies Inc (A) Shares Fall 3.3% -- GF Value Says S - GuruFocus
Agilent Technologies Inc. Introduces The NovoStation Sample Preparation System For Automated Flow Cytometry Workflows - marketscreener.com
$1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth This Much Today - Benzinga
Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report? - Zacks Investment Research
Agilent Technologies (A) Launches NovoStation Automation System to Enhance Flow Cytometry Workflow - GuruFocus
Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows - Yahoo Finance
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Agilent Technologies Inc. Introduces Agilent Biotek Gen5 Ai Cell Identification Module - marketscreener.com
Bullish on Agilent Technologies Inc - The Globe and Mail
Agilent Ekes on Launch of BioTek - tradingview.com
Agilent launches AI cell identification software module - Investing.com
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers - Yahoo Finance
A4881169 Bond Profile: Coupon and Redemption - tradingview.com
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent Technologies Inc (A): GF Score of 96 Signals Strong Outp - GuruFocus
BofA Securities Maintains Agilent Technologies(A.US) With Buy Rating, Maintains Target Price $180 - Moomoo
Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story - Yahoo Finance
Agilent Technologies Inc (A) Shares Surge 4.5% -- What GF Score of 93 Tells Investors - GuruFocus
Why Agilent Technologies (A) Stock Is Up Today - Moomoo
AGILENT TECHNOLOGIES, INC. SEC Filing (Sep 24, 2026) - Stock Titan
If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now - Zacks Investment Research
If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance
If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now - easternprogress.com
Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation - Yahoo Finance
Agilent Technologies Inc. stock outperforms competitors on strong trading day - marketwatch.com
Agilent Technologies price pierces price targetForecast today22-09-2026 - Economies.com
Global Metabolomics Market to Reach US$9.01 Billion by 2035 as Precision Medicine, Biomarker Discovery and Advanced Analytics Unlock New Opportunities - GlobeNewswire Inc.
Agilent Technologies stock heads into the open after a 3.3% gain - AD HOC NEWS
Agilent Technologies Inc (A) Stock Up 3.5% but GF Value Says Ove - GuruFocus
Agilent Technologies Inc. stock outperforms competitors on strong trading day - marketwatch.com
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent Technologies Inc (A): GF Score of 96 Signals Strong Outp - GuruFocus
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control - Yahoo Finance
Goldman Sachs Adjusts PT on Agilent Technologies to $185 From $175, Maintains Buy Rating - Moomoo
Goldman Sachs Adjusts PT on Agilent Technologies to $185 From $175, Maintains Buy Rating - marketscreener.com
Goldman Sachs Adjusts PT on Agilent Technologies to $185 From $175, Maintains Buy Rating - Yahoo Finance
Agilent Technologies, Inc. (A) Stock Analysis: Unveiling a 11.81% Potential Upside in Diagnostics & Research - DirectorsTalk Interviews
Magnetic Bead Purification Kits Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share Outlook - GlobeNewswire Inc.
Agilent (A) Wants Pathology Labs To Go Digital, 540 Slides At A Time - Yahoo Finance
애질런트 테크놀로지스 (A) 재무 분석
매출
순이익
현금흐름
주당 순 이익
애질런트 테크놀로지스 주식 (A) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Dolsten Mikael | Director |
Sep 04 '26 |
Proposed Sale |
151.38 |
634 |
95,972 |
0 |
| Dolsten Mikael | Director |
May 29 '26 |
Proposed Sale |
135.42 |
1,600 |
216,672 |
0 |
| Dolsten Mikael | Director |
May 29 '26 |
Sale |
135.42 |
1,600 |
216,672 |
5,548 |
| Dolsten Mikael | Director |
Dec 01 '25 |
Proposed Sale |
149.81 |
2,600 |
389,510 |
0 |
| Dolsten Mikael | Director |
Dec 01 '25 |
Sale |
149.81 |
2,600 |
389,511 |
4,973 |
| Gonsalves Rodney | Officer |
Nov 26 '25 |
Proposed Sale |
154.99 |
3,000 |
464,956 |
0 |
| Gonsalves Rodney | V.P., Corporate Controller |
Nov 26 '25 |
Sale |
154.99 |
3,000 |
464,956 |
31,846 |
| MCDONNELL PADRAIG | President and CEO |
Nov 18 '25 |
Sale |
143.24 |
911 |
130,492 |
32,058 |
| MCDONNELL PADRAIG | Officer |
Nov 18 '25 |
Proposed Sale |
143.24 |
911 |
130,492 |
0 |
| MCDONNELL PADRAIG | President and CEO |
Nov 12 '25 |
Option Exercise |
109.86 |
12,490 |
1,372,151 |
45,938 |
3.45%
1.41%
자본화:
|
볼륨(24시간):